Position in PRTA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$99,970
New position
Shares Held
10,285
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026JBF Capital, Inc. holds $6,440,392 across 7 Biotechnology names. PRTA ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,000 | $3,863,200 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
20,887 | $829,631 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
20,532 | $826,002 | |
| 4 | COYA |
Coya Therapeutics, Inc.
|
100,006 | $394,023 | |
| 5 | ABUS |
Arbutus Biopharma Corp
|
80,281 | $361,264 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
This page
|
10,285 | $99,970 | |
| 7 | LSTA |
Lisata Therapeutics, Inc.
|
13,234 | $66,302 |
All Filings in PRTA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,970 | 10,285 | Shares | Other | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||